1
SCHOLAR ROCK HLDG CORP
COM
SRRK
SRRK
9,575,013
$526.6m10.69%
10.69%
Reduced Shares held: Q3 2025 9.3m, Q4 2025 10.8m, Q1 2026 10.8m, Q2 2026 9.6m
-1.2m
-1,250,000
-11.6%
2
KYMERA THERAPEUTICS INC
COM
KYMR
KYMR
2,935,830
$336.7m6.83%
6.83%
Reduced Shares held: Q3 2025 3.4m, Q4 2025 3.3m, Q1 2026 3.2m, Q2 2026 2.9m
-251.0k
-251,000
-7.9%
3
ERASCA INC
COM
ERAS
ERAS
11,397,781
$208.8m4.24%
4.24%
Added Shares held: Q3 2025 8.8m, Q4 2025 8.8m, Q1 2026 11.2m, Q2 2026 11.4m
+153.5k
+153,535
1.4%
4
VERADERMICS INC
COMMON STOCK
MANE
MANE
1,655,374
$203.5m4.13%
4.13%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.5m, Q2 2026 1.7m
+150.0k
+150,000
10.0%
5
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
6,179,364
$193.2m3.92%
3.92%
Added Shares held: Q3 2025 5.9m, Q4 2025 8.2m, Q1 2026 5.7m, Q2 2026 6.2m
+522.3k
+522,259
9.2%
6
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
900,000
$168.6m3.42%
3.42%
Reduced Shares held: Q3 2025 1.0m, Q4 2025 1.3m, Q1 2026 1.1m, Q2 2026 900.0k
-211.0k
-210,980
-19.0%
7
BICARA THERAPEUTICS INC
COM
BCAX
BCAX
5,602,970
$166.4m3.38%
3.38%
Reduced Shares held: Q3 2025 5.2m, Q4 2025 5.2m, Q1 2026 5.8m, Q2 2026 5.6m
-200.0k
-200,000
-3.5%
8
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
1,715,476
$139.8m2.84%
2.84%
Added Shares held: Q3 2025 2.7m, Q4 2025 1.5m, Q1 2026 1.6m, Q2 2026 1.7m
+100.0k
+100,000
6.2%
9
BEIGENE LTD
SPONSORED ADR
ONC
ONC
465,000
$132.5m2.69%
2.69%
Unchanged Shares held: Q3 2025 493.0k, Q4 2025 500.0k, Q1 2026 465.0k, Q2 2026 465.0k
10
EDGEWISE THERAPEUTICS INC
COM
EWTX
EWTX
3,184,629
$129.4m2.63%
2.63%
Reduced Shares held: Q3 2025 3.9m, Q4 2025 4.5m, Q1 2026 4.4m, Q2 2026 3.2m
-1.2m
-1,245,634
-28.1%
11
RHYTHM PHARMACEUTICALS INC
COM
RYTM
RYTM
1,136,275
$126.2m2.56%
2.56%
Added Shares held: Q3 2025 500.0k, Q4 2025 500.0k, Q1 2026 725.5k, Q2 2026 1.1m
+410.8k
+410,764
56.6%
12
LEXICON PHARMACEUTICALS INC
COM NEW
LXRX
LXRX
44,303,518
$106.3m2.16%
2.16%
Unchanged Shares held: Q3 2025 38.9m, Q4 2025 38.9m, Q1 2026 44.3m, Q2 2026 44.3m
13
ENLIVEN THERAPEUTICS INC
COM
ELVN
ELVN
1,774,411
$90.1m1.83%
1.83%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 746.2k, Q2 2026 1.8m
+1.0m
+1,028,185
137.8%
14
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
968,598
$86.0m1.75%
1.75%
Added Shares held: Q3 2025 368.6k, Q4 2025 818.6k, Q1 2026 818.6k, Q2 2026 968.6k
+150.0k
+150,000
18.3%
15
PARABILIS MEDICINES INC
COM
PBLS
PBLS
2,992,259
$81.9m1.66%
1.66%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.0m
16
XENON PHARMACEUTICALS INC
COM
XENE
XENE
1,318,564
$79.6m1.62%
1.62%
Unchanged Shares held: Q3 2025 812.8k, Q4 2025 812.8k, Q1 2026 1.3m, Q2 2026 1.3m
17
SOLID BIOSCIENCES INC
COM NEW
SLDB
SLDB
7,690,405
$76.8m1.56%
1.56%
Unchanged Shares held: Q3 2025 7.4m, Q4 2025 7.7m, Q1 2026 7.7m, Q2 2026 7.7m
18
ABIVAX SA
SPONSORED ADS
ABVX
ABVX
576,000
$76.8m1.56%
1.56%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 576.0k
19
HEMAB THERAPEUTICS HLDGS INC
COM SHS
COAG
COAG
2,086,834
$76.6m1.56%
1.56%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.1m
20
ARCUS BIOSCIENCES INC
COM
RCUS
RCUS
2,420,430
$74.6m1.51%
1.51%
Reduced Shares held: Q3 2025 2.9m, Q4 2025 3.0m, Q1 2026 3.0m, Q2 2026 2.4m
-586.6k
-586,647
-19.5%
21
COGENT BIOSCIENCES INC
COM
COGT
COGT
1,859,279
$72.0m1.46%
1.46%
Added Shares held: Q3 2025 1.7m, Q4 2025 1.6m, Q1 2026 1.7m, Q2 2026 1.9m
+150.0k
+150,000
8.8%
22
RELAY THERAPEUTICS INC
COM
RLAY
RLAY
3,650,000
$68.3m1.39%
1.39%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.6m
23
TAYSHA GENE THERAPIES INC
COM SHS
TSHA
TSHA
9,846,579
$67.1m1.36%
1.36%
Added Shares held: Q3 2025 11.0m, Q4 2025 10.1m, Q1 2026 8.8m, Q2 2026 9.8m
+1.0m
+1,016,666
11.5%
24
DEFINIUM THERAPEUTICS INC
COM SHS
DFTX
DFTX
1,419,493
$66.8m1.36%
1.36%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 919.5k, Q2 2026 1.4m
+500.0k
+500,000
54.4%
25
STOKE THERAPEUTICS INC
COM
STOK
STOK
1,995,347
$65.3m1.33%
1.33%
Unchanged Shares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 2.0m, Q2 2026 2.0m
26
DISC MEDICINE INC
COM
IRON
IRON
888,401
$65.0m1.32%
1.32%
Reduced Shares held: Q3 2025 913.4k, Q4 2025 988.4k, Q1 2026 988.4k, Q2 2026 888.4k
-100.0k
-100,000
-10.1%
27
CYTOKINETICS INC
COM NEW
CYTK
CYTK
758,952
$64.7m1.31%
1.31%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 614.0k, Q2 2026 759.0k
+145.0k
+145,000
23.6%
28
SEPTERNA INC
COM
SEPN
SEPN
1,900,000
$63.6m1.29%
1.29%
Reduced Shares held: Q3 2025 2.2m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 1.9m
-100.0k
-100,000
-5.0%
29
OLEMA PHARMACEUTICALS INC
COM
OLMA
OLMA
4,856,949
$60.8m1.23%
1.23%
Added Shares held: Q3 2025 0, Q4 2025 3.3m, Q1 2026 4.8m, Q2 2026 4.9m
+100.0k
+100,000
2.1%
30
CRINETICS PHARMACEUTICALS IN
COM
CRNX
CRNX
1,420,788
$53.2m1.08%
1.08%
Reduced Shares held: Q3 2025 1.7m, Q4 2025 1.5m, Q1 2026 1.9m, Q2 2026 1.4m
-482.8k
-482,848
-25.4%
31
KAILERA THERAPEUTICS INC
COMMON STOCK
KLRA
KLRA
2,214,286
$48.8m0.99%
0.99%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.2m
32
DYNE THERAPEUTICS INC
COM
DYN
DYN
2,129,125
$47.3m0.96%
0.96%
Reduced Shares held: Q3 2025 4.7m, Q4 2025 3.5m, Q1 2026 2.2m, Q2 2026 2.1m
-100.0k
-100,000
-4.5%
33
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
872,967
$46.9m0.95%
0.95%
Reduced Shares held: Q3 2025 1.0m, Q4 2025 1.1m, Q1 2026 1.3m, Q2 2026 873.0k
-455.7k
-455,731
-34.3%
34
TABOOLA.COM LTD
ORD SHS
TBLA
TBLA
8,423,410
$42.1m0.86%
0.86%
Reduced Shares held: Q3 2025 10.0m, Q4 2025 10.0m, Q1 2026 10.0m, Q2 2026 8.4m
-1.5m
-1,546,085
-15.5%
35
PALVELLA THERAPEUTICS INC NE
COM
PVLA
PVLA
257,485
$39.3m0.80%
0.80%
Unchanged Shares held: Q3 2025 0, Q4 2025 75.0k, Q1 2026 257.5k, Q2 2026 257.5k
36
SILENCE THERAPEUTICS PLC
ADS
SLN
SLN
3,311,438
$36.4m0.74%
0.74%
Added Shares held: Q3 2025 2.9m, Q4 2025 2.9m, Q1 2026 2.9m, Q2 2026 3.3m
+400.0k
+400,000
13.7%
37
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
1,396,513
$35.9m0.73%
0.73%
Unchanged Shares held: Q3 2025 821.5k, Q4 2025 1.4m, Q1 2026 1.4m, Q2 2026 1.4m
38
REMITLY GLOBAL INC
COM
RELY
RELY
1,543,271
$34.6m0.70%
0.70%
Unchanged Shares held: Q3 2025 1.6m, Q4 2025 1.6m, Q1 2026 1.5m, Q2 2026 1.5m
39
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
1,893,410
$34.5m0.70%
0.70%
Added Shares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 1.2m, Q2 2026 1.9m
+700.0k
+700,000
58.7%
40
CAPITAL ONE FINL CORP
COM
COF
COF
171,615
$34.4m0.70%
0.70%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 171.6k
41
TREVI THERAPEUTICS INC
COM
TRVI
TRVI
1,786,867
$33.3m0.68%
0.68%
Unchanged Shares held: Q3 2025 2.5m, Q4 2025 2.3m, Q1 2026 1.8m, Q2 2026 1.8m
42
ORIC PHARMACEUTICALS INC
COM
ORIC
ORIC
2,998,192
$32.5m0.66%
0.66%
Unchanged Shares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 3.0m, Q2 2026 3.0m
43
ALPHABET INC
CAP STK CL A
GOOGL
GOOGL
90,000
$32.2m0.65%
0.65%
Added Shares held: Q3 2025 21.2k, Q4 2025 20.7k, Q1 2026 65.7k, Q2 2026 90.0k
+24.3k
+24,297
37.0%
44
DBV TECHNOLOGIES S A
SPONSORED ADS
DBVT
DBVT
1,857,362
$30.5m0.62%
0.62%
Unchanged Shares held: Q3 2025 0, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
45
ABSCI CORPORATION
COM
ABSI
ABSI
2,474,764
$28.7m0.58%
0.58%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.8m, Q2 2026 2.5m
+674.8k
+674,764
37.5%
46
SIONNA THERAPEUTICS INC
COM
SION
SION
610,515
$26.9m0.55%
0.55%
Added Shares held: Q3 2025 325.0k, Q4 2025 300.0k, Q1 2026 300.0k, Q2 2026 610.5k
+310.5k
+310,515
103.5%
47
RAPPORT THERAPEUTICS INC
COM
RAPP
RAPP
641,469
$26.7m0.54%
0.54%
Unchanged Shares held: Q3 2025 1.1m, Q4 2025 708.5k, Q1 2026 641.5k, Q2 2026 641.5k
48
AMYLYX PHARMACEUTICALS INC
COM
AMLX
AMLX
1,480,586
$26.6m0.54%
0.54%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.5m
+250.6k
+250,586
20.4%
49
ANNEXON INC
COM
ANNX
ANNX
4,458,646
$25.5m0.52%
0.52%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.0m, Q2 2026 4.5m
+500.0k
+500,000
12.6%
50
MONOPAR THERAPEUTICS INC
COM NEW
MNPR
MNPR
270,118
$25.0m0.51%
0.51%
Unchanged Shares held: Q3 2025 0, Q4 2025 212.3k, Q1 2026 270.1k, Q2 2026 270.1k
51
ORUKA THERAPEUTICS INC
COM
ORKA
ORKA
250,000
$23.8m0.48%
0.48%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
52
SEAPORT THERAPEUTICS INC
COMMON STOCK
SPTX
SPTX
1,095,316
$23.8m0.48%
0.48%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
53
DAMORA THERAPEUTICS INC
COM NEW
COM NEW
900,000
$23.4m0.48%
0.48%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 900.0k, Q2 2026 900.0k
54
TYRA BIOSCIENCES INC
COM
TYRA
TYRA
725,000
$23.2m0.47%
0.47%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 725.0k
55
ZURA BIO LTD
CLASS A ORD SHS
ZURA
ZURA
3,734,866
$22.0m0.45%
0.45%
Unchanged Shares held: Q3 2025 0, Q4 2025 1.3m, Q1 2026 3.7m, Q2 2026 3.7m
56
TAIWAN SEMICONDUCTOR MFG LTD
SPONSORED ADS
TSM
TSM
44,700
$21.3m0.43%
0.43%
Added Shares held: Q3 2025 28.2k, Q4 2025 27.7k, Q1 2026 42.2k, Q2 2026 44.7k
+2.5k
+2,500
5.9%
57
NVIDIA CORPORATION
COM
NVDA
NVDA
95,000
$19.0m0.39%
0.39%
Added Shares held: Q3 2025 37.5k, Q4 2025 37.5k, Q1 2026 89.1k, Q2 2026 95.0k
+5.9k
+5,915
6.6%
58
REZOLUTE INC
COM NEW
RZLT
RZLT
3,328,287
$17.3m0.35%
0.35%
Unchanged Shares held: Q3 2025 4.9m, Q4 2025 0, Q1 2026 3.3m, Q2 2026 3.3m
59
MAPLIGHT THERAPEUTICS INC
COM
MPLT
MPLT
450,000
$16.1m0.33%
0.33%
Unchanged Shares held: Q3 2025 0, Q4 2025 450.0k, Q1 2026 450.0k, Q2 2026 450.0k
60
NEUMORA THERAPEUTICS INC.
COM
NMRA
NMRA
8,497,822
$14.4m0.29%
0.29%
Unchanged Shares held: Q3 2025 4.4m, Q4 2025 6.3m, Q1 2026 8.5m, Q2 2026 8.5m
61
NEBIUS GROUP N.V.
SHS CLASS A
NBIS
NBIS
52,000
$14.4m0.29%
0.29%
Reduced Shares held: Q3 2025 72.6k, Q4 2025 76.2k, Q1 2026 113.6k, Q2 2026 52.0k
-61.6k
-61,614
-54.2%
62
MICROSOFT CORP
COM
MSFT
MSFT
37,500
$14.0m0.28%
0.28%
Reduced Shares held: Q3 2025 17.1k, Q4 2025 15.0k, Q1 2026 41.4k, Q2 2026 37.5k
-3.9k
-3,880
-9.4%
63
CYTOMX THERAPEUTICS INC
COM
CTMX
CTMX
3,457,711
$13.0m0.26%
0.26%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.5m, Q2 2026 3.5m
64
GENERATE BIOMEDICINES INC
COM SHS
GENB
GENB
736,104
$12.4m0.25%
0.25%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 736.1k, Q2 2026 736.1k
65
INHIBIKASE THERAPEUTICS INC
COM NEW
IKT
IKT
5,850,000
$11.9m0.24%
0.24%
Unchanged Shares held: Q3 2025 0, Q4 2025 5.8m, Q1 2026 5.8m, Q2 2026 5.8m
66
ADAGENE INC
ADS
ADAG
ADAG
2,666,666
$11.2m0.23%
0.23%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.7m
67
ENGENE THERAPEUTICS INC
COM
ENGN
ENGN
6,256,662
$10.8m0.22%
0.22%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.3m
68
AADI BIOSCIENCE INC
COM
WHWK
WHWK
2,337,102
$10.7m0.22%
0.22%
Added Shares held: Q3 2025 2.1m, Q4 2025 2.1m, Q1 2026 2.1m, Q2 2026 2.3m
+255.1k
+255,102
12.2%
69
DATADOG INC
CL A COM
DDOG
DDOG
40,000
$10.4m0.21%
0.21%
Reduced Shares held: Q3 2025 32.9k, Q4 2025 36.4k, Q1 2026 54.3k, Q2 2026 40.0k
-14.3k
-14,300
-26.3%
70
SERVICENOW INC
COM
NOW
NOW
100,000
$9.9m0.20%
0.20%
Added Shares held: Q3 2025 35.6k, Q4 2025 35.6k, Q1 2026 87.1k, Q2 2026 100.0k
+12.9k
+12,910
14.8%
71
BROADCOM INC
COM
AVGO
AVGO
25,000
$9.4m0.19%
0.19%
Added Shares held: Q3 2025 0, Q4 2025 7.0k, Q1 2026 15.0k, Q2 2026 25.0k
+10.0k
+10,000
66.7%
72
IONQ INC
COM
IONQ
IONQ
170,000
$9.1m0.18%
0.18%
Unchanged Shares held: Q3 2025 170.0k, Q4 2025 170.0k, Q1 2026 170.0k, Q2 2026 170.0k
73
JFROG LTD
ORD SHS
FROG
FROG
95,500
$8.7m0.18%
0.18%
Reduced Shares held: Q3 2025 107.1k, Q4 2025 93.6k, Q1 2026 128.8k, Q2 2026 95.5k
-33.3k
-33,316
-25.9%
74
OCULIS HOLDING AG
ORDINARY SHARES
OCS
OCS
625,000
$8.7m0.18%
0.18%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 625.0k
75
IREN LIMITED
ORDINARY SHARES
IREN
IREN
175,000
$8.0m0.16%
0.16%
Added Shares held: Q3 2025 20.0k, Q4 2025 43.1k, Q1 2026 43.1k, Q2 2026 175.0k
+131.9k
+131,900
306.0%
76
AMAZON COM INC
COM
AMZN
AMZN
32,500
$7.7m0.16%
0.16%
Reduced Shares held: Q3 2025 58.5k, Q4 2025 51.5k, Q1 2026 46.6k, Q2 2026 32.5k
-14.1k
-14,141
-30.3%
77
CROWDSTRIKE HLDGS INC
CL A
CRWD
CRWD
10,000
$7.6m0.15%
0.15%
Reduced Shares held: Q3 2025 18.5k, Q4 2025 16.5k, Q1 2026 23.1k, Q2 2026 10.0k
-13.1k
-13,070
-56.6%
78
DESIGN THERAPEUTICS INC
COM
DSGN
DSGN
523,212
$7.6m0.15%
0.15%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 523.2k
79
PDD HOLDINGS INC
SPONSORED ADS
PDD
PDD
95,000
$7.2m0.15%
0.15%
Added Shares held: Q3 2025 43.4k, Q4 2025 63.4k, Q1 2026 83.4k, Q2 2026 95.0k
+11.6k
+11,599
13.9%
80
SATELLOS BIOSCIENCE INC
COM
MSLE
MSLE
892,074
$6.9m0.14%
0.14%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 892.1k, Q2 2026 892.1k
81
DYNATRACE INC
COM NEW
DT
DT
155,000
$6.8m0.14%
0.14%
Added Shares held: Q3 2025 100.2k, Q4 2025 115.2k, Q1 2026 150.0k, Q2 2026 155.0k
+5.0k
+5,000
3.3%
82
TENAX THERAPEUTICS INC
COM NEW
TENX
TENX
427,141
$6.2m0.13%
0.13%
Unchanged Shares held: Q3 2025 352.4k, Q4 2025 427.1k, Q1 2026 427.1k, Q2 2026 427.1k
83
VTV THERAPEUTICS INC
CL A NEW
VTVT
VTVT
163,000
$6.1m0.12%
0.12%
Unchanged Shares held: Q3 2025 163.0k, Q4 2025 163.0k, Q1 2026 163.0k, Q2 2026 163.0k
84
ELOXX PHARMACEUTICALS INC
COM NEW
ELOX
ELOX
400,000
$5.6m0.11%
0.11%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 400.0k
85
AGOMAB THERAPEUTICS NV
SPONSORED ADS
AGMB
AGMB
411,250
$5.3m0.11%
0.11%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 411.2k, Q2 2026 411.2k
86
ALIBABA GROUP HLDG LTD
SPONSORED ADS
BABA
BABA
50,000
$4.8m0.10%
0.10%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 50.0k
87
KORRO BIO INC
COM
KRRO
KRRO
347,718
$4.6m0.09%
0.09%
Unchanged Shares held: Q3 2025 418.8k, Q4 2025 347.7k, Q1 2026 347.7k, Q2 2026 347.7k
88
CELLEBRITE DI LTD
ORDINARY SHARES
CLBT
CLBT
311,544
$4.5m0.09%
0.09%
Unchanged Shares held: Q3 2025 90.0k, Q4 2025 150.0k, Q1 2026 311.5k, Q2 2026 311.5k
89
INVIVYD INC
COM
IVVD
IVVD
5,000,000
$4.4m0.09%
0.09%
Added Shares held: Q3 2025 0, Q4 2025 4.0m, Q1 2026 4.0m, Q2 2026 5.0m
+1.0m
+1,000,000
25.0%
90
OUSTER INC
COM NEW
OUST
OUST
67,500
$4.2m0.09%
0.09%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 67.5k
91
PALISADE BIO INC
COM
PALI
PALI
2,000,000
$4.2m0.08%
0.08%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.0m
92
AEVA TECHNOLOGIES INC
COM NEW
AEVA
AEVA
145,459
$4.2m0.08%
0.08%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 110.0k, Q2 2026 145.5k
+35.5k
+35,459
32.2%
93
SEER INC
COM CL A
SEER
SEER
2,458,673
$4.1m0.08%
0.08%
Unchanged Shares held: Q3 2025 4.0m, Q4 2025 4.0m, Q1 2026 2.5m, Q2 2026 2.5m
94
I MAB
SPONSORED ADS
NBP
NBP
2,004,739
$3.9m0.08%
0.08%
Reduced Shares held: Q3 2025 1.2m, Q4 2025 3.0m, Q1 2026 3.0m, Q2 2026 2.0m
-995.3k
-995,261
-33.2%
95
GITLAB INC
CLASS A COM
GTLB
GTLB
125,000
$3.8m0.08%
0.08%
Added Shares held: Q3 2025 64.0k, Q4 2025 99.0k, Q1 2026 100.0k, Q2 2026 125.0k
+25.0k
+25,000
25.0%
96
ODYSSEY THERAPEUTICS INC
COMMON STOCK
ODTX
ODTX
200,000
$3.7m0.08%
0.08%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
97
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
720,720
$3.5m0.07%
0.07%
Unchanged Shares held: Q3 2025 720.7k, Q4 2025 720.7k, Q1 2026 720.7k, Q2 2026 720.7k
98
AGENUS INC
COM NEW
AGEN
AGEN
1,064,250
$3.3m0.07%
0.07%
Unchanged Shares held: Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m
99
MONDAY COM LTD
SHS
MNDY
MNDY
42,500
$3.1m0.06%
0.06%
Added Shares held: Q3 2025 7.0k, Q4 2025 17.0k, Q1 2026 25.0k, Q2 2026 42.5k
+17.5k
+17,500
70.0%
100
ZOETIS INC
CL A
ZTS
ZTS
35,000
$2.5m0.05%
0.05%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 35.0k